Señales en vivo de MTP | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 mar 2023 @ 15:59):

Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally...

Stats
Volumen de hoy	164 362
Volumen promedio	1.84M
Capitalización de mercado	1.98M
EPS	$0 ( 2023-04-25 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.138
ATR14	$0.0550 (41.79%)

Insider Trading

Date	Person	Action	Amount	type
2011-05-10	Kiley Quinn Thomas	Buy	1 000	MLP & Strategic Equity Fund
2010-10-06	Zimmerman Gifford R	Buy	0
2010-10-06	Toth Terence J	Buy	0
2010-10-06	Schneider William J	Buy	0
2010-10-06	Martin Larry W	Buy	0

INSIDER POWER
0.00
Last 1 transactions
Buy: 1 000 \| Sell: 0

Volumen Correlación

Largo: -0.24 (neutral)

Corto: -0.59 (weak negative)

Signal:(26.463) Neutral

Midatech Pharma PLC Correlación

10 Correlaciones Más Positivas
FWRD	0.961
GOVX	0.961
PETS	0.948
AGFY	0.947
RIDE	0.944
ENNV	0.944
CFRX	0.944
SOLO	0.941
MYMD	0.94
SINT	0.937

10 Correlaciones Más Negativas
TIOAU	-0.963
VLAT	-0.959
LDHA	-0.958
HORI	-0.956
APXI	-0.954
GEEX	-0.952
AGGR	-0.951
LEGA	-0.95
HCNE	-0.949
LVRA	-0.948

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Midatech Pharma PLC Correlación - Moneda/Commodity

-0.80
( moderate negative )

-0.46
( neutral )

0.00
( neutral )

-0.40
( neutral )

0.78
( moderate )

Midatech Pharma PLC Finanzas

Annual	2022
Ingresos:	$699 000
Beneficio Bruto:	$-4.41M (-631.19 %)
EPS:	$0

FY	2022
Ingresos:	$699 000
Beneficio Bruto:	$-4.41M (-631.19 %)
EPS:	$0

FY	2021
Ingresos:	$578 000
Beneficio Bruto:	$-4.08M (-705.19 %)
EPS:	$-1.695

FY	2020
Ingresos:	$180 000
Beneficio Bruto:	$-5.89M (-3 271.11 %)
EPS:	$-258.98

Financial Reports:

No articles found.

Midatech Pharma PLC

Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.